The EU Commission has determined to not renew COVID-19 vaccine contracts subsequent 12 months with AstraZeneca and Johnson & Johnson (J&J), Italian each day La Stampa reported on Wednesday, citing a supply from the Italian well being ministry.
“The European Commission, in agreement with the leaders of many (EU) countries, has decided that the contracts with the companies that produce (viral vector) vaccines that are valid for the current year will not be renewed at their expiry,” the newspaper reported.
It added that Brussels would relatively give attention to COVID-19 vaccines utilizing messenger RNA (mRNA) expertise, corresponding to Pfizer’s and Moderna’s.
A spokesman for the EU Commission mentioned it was conserving all choices open to be ready for the following levels of the pandemic, for 2022 and past.
“We cannot, however, comment on contractual issues,” the spokesman added.
The Italian well being ministry declined to remark.
The European Commission is searching for clarification from J&J concerning the firm’s “completely unexpected” announcement of delays in COVID-19 vaccine deliveries to the EU, an EU official advised Reuters on Tuesday.
(Except for the headline, this story has not been edited by LiveNews360 employees and is revealed from a syndicated feed.)